# Lu Yao

> Lu Yao holds a position at Peking University Cancer Hospital, recorded in ORCID since 2009. Their published research is indexed in Biochemistry, Genetics and Molecular Biology, specifically Genetics, across 22 works listed on their ORCID profile. Recent indexed output includes “Single-Cell Immune Signature and Response to Neoadjuvant Chemotherapy in BRCA1/2 -Mutated Breast Cancer” (2025) and “Clinical Impact and Genomic Features of Human Epidermal Growth Factor Receptor 2–Low Tumors in BRCA1/2 -Mutated…” (2025).

*Source: [https://selltoscientists.com/researchers/lu-yao/](https://selltoscientists.com/researchers/lu-yao/)*

**Institution:** Peking University Cancer Hospital
**Field:** Biochemistry, Genetics and Molecular Biology
**ORCID:** `0000-0002-6430-8712`

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product